Suppr超能文献

使用FTY720进行免疫抑制可逆转低表达SR-BI的低表达载脂蛋白E小鼠的心脏功能障碍,这些小鼠在冠状动脉粥样硬化引起的心肌梗死中存活下来。

Immunosuppression With FTY720 Reverses Cardiac Dysfunction in Hypomorphic ApoE Mice Deficient in SR-BI Expression That Survive Myocardial Infarction Caused by Coronary Atherosclerosis.

作者信息

Luk Fu Sang, Kim Roy Y, Li Kang, Ching Daniel, Wong David K, Joshi Sunil K, Imhof Isabella, Honbo Norman, Hoover Holly, Zhu Bo-Qing, Lovett David H, Karliner Joel S, Raffai Robert L

机构信息

Departments of *Surgery; and †Medicine, San Francisco VA Medical Center, University of California, San Francisco, San Francisco, CA.

出版信息

J Cardiovasc Pharmacol. 2016 Jan;67(1):47-56. doi: 10.1097/FJC.0000000000000312.

Abstract

AIMS

We recently reported that immunosuppression with FTY720 improves cardiac function and extends longevity in Hypomorphic ApoE mice deficient in scavenger receptor Type-BI expression, also known as the HypoE/SR-BI(–/–) mouse model of diet-induced coronary atherosclerosis and myocardial infarction (MI). In this study, we tested the impact of FTY720 on cardiac dysfunction in HypoE/SR-BI(–/–) mice that survive MI and subsequently develop chronic heart failure.

METHODS/RESULTS: HypoE/SR-BI(–/–) mice were bred to Mx1-Cre transgenic mice, and offspring were fed a high-fat diet (HFD) for 3.5 weeks to provoke hyperlipidemia, coronary atherosclerosis, and recurrent MIs. In contrast to our previous study, hyperlipidemia was rapidly reversed by inducible Cre-mediated gene repair of the HypoE allele and switching mice to a normal chow diet. Mice that survived the period of HFD were subsequently given oral FTY720 in drinking water or not, and left ventricular (LV) function was monitored using serial echocardiography for up to 15 weeks. In untreated mice, LV performance progressively deteriorated. Although FTY720 treatment did not initially prevent a decline of heart function among mice 6 weeks after Cre-mediated gene repair, it almost completely restored normal LV function in these mice by 15 weeks. Reversal of heart failure did not result from reduced atherosclerosis as the burden of aortic and coronary atherosclerosis actually increased to similar levels in both groups of mice. Rather, FTY720 caused systemic immunosuppression as assessed by reduced numbers of circulating T and B lymphocytes. In contrast, FTY720 did not enhance the loss of T cells or macrophages that accumulated in the heart during the HFD feeding period, but it did enhance the loss of B cells soon after plasma lipid lowering. Moreover, FTY720 potently reduced the expression of matrix metalloproteinase-2 and genes involved in innate immunity-associated inflammation in the heart.

CONCLUSIONS

Our data demonstrate that immunosuppression with FTY720 prevents postinfarction myocardial remodeling and chronic heart failure.

摘要

目的

我们最近报道,在低表达清道夫受体BI(也称为饮食诱导的冠状动脉粥样硬化和心肌梗死(MI)的HypoE/SR-BI(–/–)小鼠模型)的低表达载脂蛋白E(Hypomorphic ApoE)小鼠中,使用FTY720进行免疫抑制可改善心脏功能并延长寿命。在本研究中,我们测试了FTY720对MI存活并随后发展为慢性心力衰竭的HypoE/SR-BI(–/–)小鼠心脏功能障碍的影响。

方法/结果:将HypoE/SR-BI(–/–)小鼠与Mx1-Cre转基因小鼠杂交,后代喂食高脂饮食(HFD)3.5周,以引发高脂血症、冠状动脉粥样硬化和复发性MI。与我们之前的研究不同,通过诱导性Cre介导的HypoE等位基因基因修复以及将小鼠改为正常的普通饮食,高脂血症迅速得到逆转。在HFD期间存活的小鼠随后在饮用水中给予或不给予口服FTY720,并使用连续超声心动图监测左心室(LV)功能长达15周。在未治疗的小鼠中,LV性能逐渐恶化。尽管FTY720治疗最初并未阻止Cre介导的基因修复后6周小鼠心脏功能的下降,但到15周时,它几乎完全恢复了这些小鼠的正常LV功能。心力衰竭的逆转并非由于动脉粥样硬化减轻,因为两组小鼠的主动脉和冠状动脉粥样硬化负担实际上都增加到了相似的水平。相反,通过循环T和B淋巴细胞数量减少评估,FTY720导致全身免疫抑制。相比之下,FTY720并未增加在HFD喂养期间心脏中积累的T细胞或巨噬细胞的损失,但在血脂降低后不久确实增加了B细胞的损失。此外,FTY720有力地降低了心脏中基质金属蛋白酶-2的表达以及与先天免疫相关炎症相关的基因表达。

结论

我们的数据表明,用FTY720进行免疫抑制可预防梗死后心肌重塑和慢性心力衰竭。

相似文献

4
SR-BI in bone marrow derived cells protects mice from diet induced coronary artery atherosclerosis and myocardial infarction.
PLoS One. 2013 Aug 13;8(8):e72492. doi: 10.1371/journal.pone.0072492. eCollection 2013.
9
Novel Mouse Model of Myocardial Infarction, Plaque Rupture, and Stroke Shows Improved Survival With Myeloperoxidase Inhibition.
Circulation. 2024 Aug 27;150(9):687-705. doi: 10.1161/CIRCULATIONAHA.123.067931. Epub 2024 Jun 17.
10
Hepatic lipase deficiency delays atherosclerosis, myocardial infarction, and cardiac dysfunction and extends lifespan in SR-BI/apolipoprotein E double knockout mice.
Arterioscler Thromb Vasc Biol. 2006 Mar;26(3):548-54. doi: 10.1161/01.ATV.0000202662.63876.02. Epub 2006 Jan 5.

引用本文的文献

2
Stromal cell-derived factor-1 alpha improves cardiac function in a novel diet-induced coronary atherosclerosis model, the SR-B1ΔCT/LDLR KO mouse.
Atherosclerosis. 2024 Aug;395:117518. doi: 10.1016/j.atherosclerosis.2024.117518. Epub 2024 Mar 22.
3
Searching for Effective Treatments in HFpEF: Implications for Modeling the Disease in Rodents.
Pharmaceuticals (Basel). 2023 Oct 12;16(10):1449. doi: 10.3390/ph16101449.
5
SR-B1-/-ApoE-R61h/h Mice Mimic Human Coronary Heart Disease.
Cardiovasc Drugs Ther. 2024 Dec;38(6):1123-1137. doi: 10.1007/s10557-023-07475-8. Epub 2023 Jun 5.
8
Sphingosine-1-phosphate signaling and the gut-liver axis in liver diseases.
Liver Res. 2019 Mar;3(1):19-24. doi: 10.1016/j.livres.2019.02.003. Epub 2019 Mar 4.
9
Novel Molecular Targets Participating in Myocardial Ischemia-Reperfusion Injury and Cardioprotection.
Cardiol Res Pract. 2019 May 28;2019:6935147. doi: 10.1155/2019/6935147. eCollection 2019.

本文引用的文献

1
Monocytes in myocardial infarction.
Arterioscler Thromb Vasc Biol. 2015 May;35(5):1066-70. doi: 10.1161/ATVBAHA.114.304652. Epub 2015 Mar 19.
2
Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling.
Circulation. 2015 Mar 17;131(11):1019-30. doi: 10.1161/CIRCULATIONAHA.114.008788.
3
The varying faces of IL-6: From cardiac protection to cardiac failure.
Cytokine. 2015 Jul;74(1):62-8. doi: 10.1016/j.cyto.2014.12.024. Epub 2015 Jan 31.
4
A N-terminal truncated intracellular isoform of matrix metalloproteinase-2 impairs contractility of mouse myocardium.
Front Physiol. 2014 Sep 25;5:363. doi: 10.3389/fphys.2014.00363. eCollection 2014.
5
STAT3 inhibitor WP1066 attenuates miRNA-21 to suppress human oral squamous cell carcinoma growth in vitro and in vivo.
Oncol Rep. 2014 May;31(5):2173-80. doi: 10.3892/or.2014.3114. Epub 2014 Mar 27.
8
Cardiac macrophages and their role in ischaemic heart disease.
Cardiovasc Res. 2014 May 1;102(2):240-8. doi: 10.1093/cvr/cvu025. Epub 2014 Feb 5.
9
The immune system and the remodeling infarcted heart: cell biological insights and therapeutic opportunities.
J Cardiovasc Pharmacol. 2014 Mar;63(3):185-95. doi: 10.1097/FJC.0000000000000003.
10
B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction.
Nat Med. 2013 Oct;19(10):1273-80. doi: 10.1038/nm.3284. Epub 2013 Sep 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验